Fortaleza Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Fortaleza Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$111K	Buy	2,935 +1,210	+70%	+$46.3K	0.9%	57
2018 Q1	$56K	Hold	1,725	–	–	0.34%	91
2017 Q4	$84K	Sell	1,725 -1,155	-40%	-$58.4K	0.53%	82
2017 Q3	$156K	Hold	2,880	–	–	0.29%	107
2017 Q2	$162K	Sell	2,880 -2,045	-42%	-$81.9K	0.31%	94
2017 Q1	$193K	Buy	+4,925	New	+$157K	0.39%	79
2016 Q1	–	Sell	-3,740	Closed	-$192K	–	212
2015 Q4	$192K	Buy	+3,740	New	+$181K	0.12%	97

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Fortaleza Asset Management's PTLA Position: Q2 2018 in Review

Fortaleza Asset Management increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 70% in Q2 2018, buying an estimated $46.3K and bringing the position to 2,935 shares worth $111K. The position accounts for 0.9% of the portfolio, ranked #57.

Fortaleza Asset Management first reported a position in PTLA in Q4 2015 and has held it in 7 quarters since. The position peaked at $193K in Q1 2017. 204 funds tracked by Wall St. Rank hold PTLA as of Q2 2018.

Fortaleza Asset Management held 2,935 shares of Portola Pharmaceuticals, Inc. worth $111K as of Q2 2018.
Fortaleza Asset Management bought 1,210 Portola Pharmaceuticals, Inc. shares in Q2 2018, an estimated $46.3K.
Portola Pharmaceuticals, Inc. made up 0.9% of Fortaleza Asset Management's portfolio in Q2 2018, its #57 holding.
Fortaleza Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and has held it in 7 quarters since.
Fortaleza Asset Management's Portola Pharmaceuticals, Inc. position peaked at $193K in Q1 2017.
204 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.